A smartphone app for monitoring hemoglobin levels in chronic anemia patients
Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients
This study is creating a friendly smartphone app that helps people with chronic anemia easily check their hemoglobin levels with just a drop of blood, so they can manage their health better without needing to visit the clinic all the time.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanguina, LLC NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11003364 on NIH RePORTER |
What this research studies
This research focuses on developing a personalized, non-invasive smartphone application that allows patients with chronic anemia to monitor their hemoglobin levels conveniently. The app utilizes a novel technology that requires only a single drop of blood for testing, making it easier for patients to manage their condition without frequent clinic visits. By providing real-time data on hemoglobin levels, the app aims to empower patients to take control of their health and improve their quality of life. The approach combines innovative technology with user-friendly design to ensure accessibility and accuracy.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with chronic anemia or are at high risk for developing anemia.
Not a fit: Patients who do not have anemia or are not at risk for anemia may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide chronic anemia patients with a convenient and cost-effective way to monitor their hemoglobin levels, leading to better management of their condition.
How similar studies have performed: Other research has shown success with similar non-invasive monitoring technologies, indicating a promising potential for this approach.
Where this research is happening
Atlanta, United States
- Sanguina, LLC — Atlanta, United States (Active)
Researchers
- Principal investigator: Tyburski, Erika Amy — Sanguina, LLC
- Study coordinator: Tyburski, Erika Amy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.